When: May 21st, 2024, from 3:00 PM to 6:00 PM (incl. drinks)
Where: Loyens & Loeff in Amsterdam
This event is for:
- Academic researchers in life sciences and medtech
- Biotech or medtech startups/spin-offs heading towards clinical trials
- Companies and stakeholders within the DCVA and RegMed XB network
Speakers include:
- Hans Schikan, experienced biopharma executive with a demonstrated history of working in biopharma.
- Eric van der Veer, PhD, founder, and Chief Innovation Officer of Hybridize Therapeutics. Spent over 12 years as postdoc at the Leiden University Medical Center working on RNA therapies & kidney diseases.
- Anke van Holthe tot Echten, a partner at Loyens & Loeff, specialized in corporate law, focusing on mergers and acquisitions, joint ventures and leveraged buy-outs.
- Femke van de Hoef, a senior associate at Loyens & Loeff, with specific expertise on venture and growth capital investments and exits of venture and growth capital-backed companies.
The speakers will share invaluable knowledge and experiences you won't want to miss. Register now and be part of this inspiring event.
The previous edition sold out quickly, so act fast to ensure your spot! Sign up via this link
For more information click here.